Literature DB >> 28067713

Widespread Down-Regulation of Cardiac Mitochondrial and Sarcomeric Genes in Patients With Sepsis.

Scot J Matkovich1, Belal Al Khiami, Igor R Efimov, Sarah Evans, Justin Vader, Ashwin Jain, Bernard H Brownstein, Richard S Hotchkiss, Douglas L Mann.   

Abstract

OBJECTIVES: The mechanism(s) for septic cardiomyopathy in humans is not known. To address this, we measured messenger RNA alterations in hearts from patients who died from systemic sepsis, in comparison to changed messenger RNA expression in nonfailing and failing human hearts.
DESIGN: Identification of genes with altered abundance in septic cardiomyopathy, ischemic heart disease, or dilated cardiomyopathy, in comparison to nonfailing hearts.
SETTING: ICUs at Barnes-Jewish Hospital, St. Louis, MO. PATIENTS: Twenty sepsis patients, 11 ischemic heart disease, nine dilated cardiomyopathy, and 11 nonfailing donors.
INTERVENTIONS: None other than those performed as part of patient care.
MEASUREMENTS AND MAIN RESULTS: Messenger RNA expression levels for 198 mitochondrially localized energy production components, including Krebs cycle and electron transport genes, decreased by 43% ± 5% (mean ± SD). Messenger RNAs for nine genes responsible for sarcomere contraction and excitation-contraction coupling decreased by 43% ± 4% in septic hearts. Surprisingly, the alterations in messenger RNA levels in septic cardiomyopathy were both distinct from and more profound than changes in messenger RNA levels in the hearts of patients with end-stage heart failure.
CONCLUSIONS: The expression profile of messenger RNAs in the heart of septic patients reveals striking decreases in expression levels of messenger RNAs that encode proteins involved in cardiac energy production and cardiac contractility and is distinct from that observed in patients with heart failure. Although speculative, the global nature of the decreases in messenger RNA expression for genes involved in cardiac energy production and contractility suggests that these changes may represent a short-term adaptive response of the heart in response to acute change in cardiovascular homeostasis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28067713      PMCID: PMC5315660          DOI: 10.1097/CCM.0000000000002207

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  25 in total

1.  Circulating substances and energy metabolism in septic shock.

Authors:  Anand Kumar; Kenneth Wood; Joseph E Parrillo
Journal:  Crit Care Med       Date:  2003-02       Impact factor: 7.598

2.  Septic cardiomyopathy: physiology of left ventricular failure.

Authors:  J D Cohn; C Timpawat; P E Engler; L R Del Guercio
Journal:  Surg Forum       Date:  1976

3.  Immunosuppression in patients who die of sepsis and multiple organ failure.

Authors:  Jonathan S Boomer; Kathleen To; Kathy C Chang; Osamu Takasu; Dale F Osborne; Andrew H Walton; Traci L Bricker; Stephen D Jarman; Daniel Kreisel; Alexander S Krupnick; Anil Srivastava; Paul E Swanson; Jonathan M Green; Richard S Hotchkiss
Journal:  JAMA       Date:  2011-12-21       Impact factor: 56.272

4.  Functional significance of the discordance between transcriptional profile and left ventricular structure/function during reverse remodeling.

Authors:  Veli K Topkara; Kari T Chambers; Kai-Chien Yang; Huei-Ping Tzeng; Sarah Evans; Carla Weinheimer; Attila Kovacs; Jeffrey Robbins; Philip Barger; Douglas L Mann
Journal:  JCI Insight       Date:  2016-04-06

5.  Reciprocal transcriptional regulation of metabolic and signaling pathways correlates with disease severity in heart failure.

Authors:  Andreas S Barth; Ami Kumordzie; Constantine Frangakis; Kenneth B Margulies; Thomas P Cappola; Gordon F Tomaselli
Journal:  Circ Cardiovasc Genet       Date:  2011-08-09

6.  Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNAs in failing human heart and remodeling with mechanical circulatory support.

Authors:  Kai-Chien Yang; Kathryn A Yamada; Akshar Y Patel; Veli K Topkara; Isaac George; Faisal H Cheema; Gregory A Ewald; Douglas L Mann; Jeanne M Nerbonne
Journal:  Circulation       Date:  2014-01-15       Impact factor: 29.690

7.  Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock.

Authors:  J F Dhainaut; M F Huyghebaert; J F Monsallier; G Lefevre; J Dall'Ava-Santucci; F Brunet; D Villemant; A Carli; D Raichvarg
Journal:  Circulation       Date:  1987-03       Impact factor: 29.690

8.  Sepsis-induced myocardial depression is associated with transcriptional changes in energy metabolism and contractile related genes: a physiological and gene expression-based approach.

Authors:  Claudia C dos Santos; David J Gattas; James N Tsoporis; Lonneke Smeding; Golam Kabir; Hussain Masoom; Ali Akram; Frans Plotz; Arthur S Slutsky; Mansoor Husain; William J Sibbald; Thomas G Parker
Journal:  Crit Care Med       Date:  2010-03       Impact factor: 7.598

Review 9.  Mitochondrial Mechanisms in Septic Cardiomyopathy.

Authors:  María Cecilia Cimolai; Silvia Alvarez; Christoph Bode; Heiko Bugger
Journal:  Int J Mol Sci       Date:  2015-08-03       Impact factor: 5.923

10.  Disruption of calcium homeostasis in cardiomyocytes underlies cardiac structural and functional changes in severe sepsis.

Authors:  Mara R N Celes; Lygia M Malvestio; Sylvia O Suadicani; Cibele M Prado; Maria J Figueiredo; Erica C Campos; Ana C S Freitas; David C Spray; Herbert B Tanowitz; João S da Silva; Marcos A Rossi
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more
  27 in total

1.  [Sharpen the classical view of septic cardiomyopathy].

Authors:  P Mirtschink; S N Stehr
Journal:  Anaesthesist       Date:  2017-07       Impact factor: 1.041

2.  Irisin ameliorates septic cardiomyopathy via inhibiting DRP1-related mitochondrial fission and normalizing the JNK-LATS2 signaling pathway.

Authors:  Ying Tan; Haichun Ouyang; Xiaochan Xiao; Jiankai Zhong; Maolong Dong
Journal:  Cell Stress Chaperones       Date:  2019-04-16       Impact factor: 3.667

Review 3.  Pathophysiology of sepsis-induced cardiomyopathy.

Authors:  Steven M Hollenberg; Mervyn Singer
Journal:  Nat Rev Cardiol       Date:  2021-01-20       Impact factor: 32.419

4.  PKCδ causes sepsis-induced cardiomyopathy by inducing mitochondrial dysfunction.

Authors:  Leroy C Joseph; Michael V Reyes; Kundanika R Lakkadi; Blake H Gowen; Gyorgy Hasko; Konstantinos Drosatos; John P Morrow
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-03-06       Impact factor: 4.733

5.  Do critical care patients hibernate? Theoretical support for less is more.

Authors:  Giacomo Stanzani; Robert Tidswell; Mervyn Singer
Journal:  Intensive Care Med       Date:  2019-11-08       Impact factor: 17.440

6.  Septic Cardiomyopathy: Getting to the Heart of the Matter.

Authors:  Timothy E Sweeney; Purvesh Khatri
Journal:  Crit Care Med       Date:  2017-03       Impact factor: 7.598

7.  The effects of UCP2 on autophagy through the AMPK signaling pathway in septic cardiomyopathy and the underlying mechanism.

Authors:  Jia-Yu Mao; Long-Xiang Su; Dong-Kai Li; Hong-Min Zhang; Xiao-Ting Wang; Da-Wei Liu
Journal:  Ann Transl Med       Date:  2021-02

Review 8.  Involvement of Mitochondrial Disorders in Septic Cardiomyopathy.

Authors:  Arthur Durand; Thibault Duburcq; Thibault Dekeyser; Remi Neviere; Michael Howsam; Raphael Favory; Sebastien Preau
Journal:  Oxid Med Cell Longev       Date:  2017-10-22       Impact factor: 6.543

Review 9.  Energetic dysfunction in sepsis: a narrative review.

Authors:  Sebastien Preau; Dominique Vodovar; Boris Jung; Steve Lancel; Lara Zafrani; Aurelien Flatres; Mehdi Oualha; Guillaume Voiriot; Youenn Jouan; Jeremie Joffre; Fabrice Uhel; Nicolas De Prost; Stein Silva; Eric Azabou; Peter Radermacher
Journal:  Ann Intensive Care       Date:  2021-07-03       Impact factor: 6.925

Review 10.  Sepsis-Induced Cardiomyopathy: Oxidative Implications in the Initiation and Resolution of the Damage.

Authors:  Vasiliki Tsolaki; Demosthenes Makris; Konstantinos Mantzarlis; Epameinontas Zakynthinos
Journal:  Oxid Med Cell Longev       Date:  2017-09-19       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.